OOIR: Observatory of International Research

Papers

(The TQCC of Thoracic Cancer is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR‐153‐3p/SATB1 signaling pathway	153
	53
Issue Information	41
Feasibility and safety of secondary video‐assisted thoracoscopic surgery for ipsilateral lung cancer after prior pulmonary resection	40
Rapid and reliable collection of tumor tissue for successful gene panel in a patient with advanced stage lung cancer: A case report	40
Multidimensional profiling depicts infiltrating immune cell heterogeneity in the tumor microenvironment of stage IA non‐small cell lung cancer	38
Pulmonary completion lobectomy after segmentectomy: An integrated analysis of perioperative outcomes	35
Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report	34
Issue Information	33
Premature phase II study of amrubicin as palliative chemotherapy for previously treated malignant pleural mesothelioma	31
Tracheal polypoid combined small cell lung cancer (C‐SCLC): A case report	30
	28
Issue Information	27
	26
Using the neutrophil‐to‐lymphocyte ratio to predict the outcome of individuals with nonsquamous non‐small cell lung cancer receiving pembrolizumab plus platinum and pemetrexed	25
Afatinib and osimertinib in lung adenocarcinoma harbored EGFR T751_I759delinsS mutation: A case report	24
Primary ciliated muconodular papillary tumor: A rare pulmonary disease and literature review of 65 cases	24
	24
Age‐related features of lung cancer treatment using reprogrammed CD8 positive T cells in mice subjected to injection of Lewis lung carcinoma cells	23
Immune‐inflammatory markers and clinical characteristics as predictors of the depth of response and prognosis of patients with PD‐L1 ≥50% metastatic non‐small cell lung cancer re	23
Construction of a nomogram model based on biomarkers for liver metastasis in non‐small cell lung cancer	23
Relationship between the combination of platelet count and neutrophil‐lymphocyte ratio and prognosis of patients with advanced non‐small cell lung cancer treated with immune checkpoint inhibitors plus	23
Delivery of miR‐3529‐3p using MnO₂‐SiO₂‐APTES nanoparticles combined with phototherapy suppresses lung adenocarcinoma progression by targeting HIGD1A	22
A Novel DNA Repair‐Gene Model to Predict Responses to Immunotherapy and Prognosis in Patients With EGFR‐Mutant Non‐Small Cell Lung Cancer	22
Regulation of ferroptosis‐related genes in CD8+ NKT cells and classical monocytes may affect the immunotherapy response after combined treatment in triple negative breast cancer	22

RETRACTION: Manganese‐12 Acetate Suppresses the Migration, Invasion, and Epithelial–Mesenchymal Transition by Inhibiting Wnt/β‐Catenin and PI3K/AKT Signaling Pathways	22
2‐methoxyestradiol restrains non‐small cell lung cancer tumorigenesis through regulating circ_0010235/miR‐34a‐5p/NFAT5 axis	21
Enhanced prediction of postoperative radiotherapy‐induced esophagitis in non‐small cell lung cancer: Dosiomic model development in a real‐world cohort and validation in the PORT‐C randomize	20
A rare case of docetaxel‐induced myositis in a patient with a lung adenocarcinoma	20
Lymph node metastasis and its risk factors in T1 lung adenocarcinoma	19
Efficacy and safety of bevacizumab combined with EGFR‐TKIs in advanced non‐small cell lung cancer: A meta‐analysis	19
Issue Information	19
Comparison of next‐generation sequencing and cobas EGFR mutation test v2 in detecting EGFR mutations	19
Rapidly developing intrathoracic low‐grade fibromyxoid sarcoma: A case report	19
Enhancing precision in lung tumor ablation through innovations in CT‐guided technique and angle control	18
Issue Information	18
LINC02323 facilitates development of lung squamous cell carcinoma by miRNA sponge and RBP dysregulation and links to poor prognosis	18
Issue Information	18
Exceptionally long‐lasting response to dabrafenib plus trametinib treatment in a patient with lung adenocarcinoma harboring the BRAF V600E mutation with high expression of PD‐L1	18
First report of an adult female patient with endobronchial inflammatory myofibroblastic tumor in Taiwan: A case report	18
Whole‐exome sequencing in primary pulmonary synovial sarcoma misdiagnosed as mesothelioma: A case report and literature review	18
Non‐small cell lung cancer with EGFR (L858R and E709X) and CNNB1 mutations responded to afatinib	17
Identification and validation of the model consisting of DDX49, EGFR, and T‐stage as a possible risk factor for lymph node metastasis in patients with lung cancer	17
Co‐occurring KEAP1 and TP53 mutations in lung squamous cell carcinoma induced primary resistance to thoracic radiotherapy: A case report	17
Issue Information	17
Real‐world treatment and prognostic factors for survival in ALK+ non‐small cell lung cancer (NSCLC) patients with brain metastases in China	17
Safety of anti‐SARS‐CoV‐2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient‐reported	16
Issue Information	16
Chest computed‐tomography 1 day before the diagnosis of coronavirus disease 2019	16
Colorectal Metastasis From Lung Adenocarcinoma With Initial Gastrointestinal Symptoms: A Case Report and Literature Review	16
Correlations between class I glucose transporter expression patterns and clinical outcomes in non‐small cell lung cancer	16
Analysis of the Clinicopathological Characteristics, Genetic Phenotypes, and Prognostics of Primary Pulmonary and Bronchial Adenoid Cystic Carcinoma	16
Postoperative Lung Function Advantages in Pulmonary Segmentectomy for Early‐Stage Lung Cancer	15
	15
	15
Identifying Risk Factors Associated With False‐Negative Results in US‐Guided Percutaneous Transthoracic Needle Lung Biopsy of Subpleural Pulmonary Lesions	15
Pathological Complete Response to a Single Dose of Pembrolizumab‐Based Chemoimmunotherapy for Squamous Cell Carcinoma of the Lung: A Case Report	15
Issue Information	15
Sodium‐Glucose Cotransporter 2 Inhibitors for Mesenchymal–Epithelial Transition Inhibitor‐Induced Edema	15
Comprehensive expressional analysis of chemosensitivity‐related markers in large cell neuroendocrine carcinoma of the lung	15
Life‐threatening extrapleural hematoma in an anticoagulated patient 2 weeks after lobectomy	15
Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer	14
Could intracranial tumor volume predict prognosis of patients with brain metastases from esophageal carcinoma?	14
Personalized cancer avatars for patients with thymic malignancies: A pilot study with circulating tumor cell‐derived organoids	14
Successful treatment of refractory brain metastases from ALK‐positive lung cancer with lorlatinib	14
Radiation therapy induces an abscopal effect and upregulates programmed death‐ligand 1 expression in a patient with non‐small cell lung cancer	14
Reporting quality of randomized, controlled trials evaluating immunotherapy in lung cancer	14
Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation	14
Pulmonary artery occlusion post immunotherapy for hilar node‐positive lung cancer	14
Predicting prognosis using a pathological tumor cell proportion in stage I lung adenocarcinoma	14
	14
Gastroesophageal reflux disease and paraneoplastic neurological syndrome associated with long‐term survival in limited stage small‐cell lung cancer	14
Neuroendocrine tumor secondary to pulmonary hypoplasia: A case report	14
Correction to “Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization	14
Impact of tumor size and location on lung dose difference between stereotactic body radiation therapy techniques for non‐small cell lung cancer	14

Electromagnetic navigational bronchoscopy‐guided dye marking to identify the subsegmental bronchus in thoracoscopic anatomic subsegmentectomy	14
Issue Information	14
Immunotherapy combined with chemotherapy versus chemotherapy alone as the first‐line treatment of PD‐L1‐negative and driver‐gene‐negative advanced nonsquamous non‐small‐cell lung cancer: An	14
A randomized phase II study of docetaxel or pemetrexed with or without the continuation of gefitinib after disease progression in elderly patients with non‐small cell lung cancer harboring	13
	13
Prevalence and management of pain in lung cancer patients in northern China: A multicenter cross‐sectional study	13
Malignant transformation of heterotopic pancreas as middle esophagus adenocarcinoma—A rare case report and comprehensive literature review	13
Issue Information	13
KIAA1429 regulates lung adenocarcinoma proliferation and metastasis through the PI3K/AKT pathway by modulating ARHGAP30 expression	13
Predicting pathological response to neoadjuvant or conversion chemoimmunotherapy in stage IB–III non‐small cell lung cancer patients using radiomic features	13
Randomized phase 2 study comparing irinotecan versus amrubicin as maintenance therapy after first‐line induction therapy for extensive disease small cell lung cancer (HOT1401/NJLCG1401	13
Icotinib alone or with bevacizumab as first‐line therapy in Chinese patients with advanced nonsquamous non‐small cell lung cancer and activating EGFR mutations: A retrospective study	13
Dysbiosis of lower respiratory tract microbiome are associated with proinflammatory states in non‐small cell lung cancer patients	13
Enhanced systemic antitumor efficacy of PD‐1/PD‐L1 blockade with immunological response induced by photodynamic therapy	13
AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines	13
An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy	13
Response to ALK‐TKIs in a lung adenocarcinoma patient harboring dual DCTN1‐ALK and ALK‐CLIP4 rearrangements	13
How to distinguish thoracic and cervical lymph nodes during minimally invasive esophagectomy	12
Issue Information	12
Thoracic myopericytoma in an older adult, rare but possible: A case report	12
Focal ¹⁸F‐FDG uptake predicts progression of pre‐invasive squamous bronchial lesions to invasive cancers	12
Left sleeve pneumonectomy via uniportal video‐assisted thoracoscopic approach	12
Clinical outcomes of EGFR+/METamp+ vs. EGFR+/METamp‐ untreated patients with advanced non‐small cell lung cancer	12
Impact of the combination of sintilimab and chemotherapy on the tumor and paratumor PD‐L1, IDO, TIM‐3, FOXP3+ and CD8 expressions in patients wit	12
	12
A rare presentation of anaplastic large cell lymphoma as a cavitary pulmonary mass with hypercalcemia	11
Adiponectin‐expressing Treg‐containing T cell fraction inhibits tumor growth in orthotopically implanted triple‐negative breast cancer	11
Clinical efficacy of amrubicin in patients with small cell lung cancer relapse after first‐line treatment including immune checkpoint inhibitors: A retrospective multicenter study (TOPGAN 2	11
Endotracheal enucleation and para‐toluenesulfonamide injection for adenoid cystic carcinoma in the upper trachea: A novel therapeutic approach	11
An extremely rare case of pulmonary epithelioid hemangioendothelioma	11
Heterogeneity or transformation? A whack‐a‐mole case of EGFR‐mutant lung adenocarcinoma and small cell carcinoma: A case report	11
Locally advanced primary mediastinal atypical carcinoid successfully resected after neoadjuvant treatment: A case report	11
Prognostic factors and survival outcome of primary pulmonary acinar cell carcinoma	11
Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report	11
A novel form of precise segmentectomy—Triumphal arch‐like anatomical segmentectomy	11
Usefulness of positron‐emission tomography for predicting the World Health Organization grade of thymic epithelial tumors	11
Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases	11
Two‐stage minimally invasive pulmonary resections with intraoperative localization technique for bilateral multiple primary lung cancers: A case report	10
Clinical definition of secondary resistance to immunotherapy in non‐small cell lung cancer	10
Programmed death‐ligand 1 expression and use of immune checkpoint inhibitors among patients with advanced non‐small‐cell lung cancer in a resource‐limited country	10
Evaluation of appropriate conditions for Oncomine DxTT testing of FFPE specimens for driver gene alterations in non–small cell lung cancer	10
Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors	10
The role of microbiota in esophageal squamous cell carcinoma: A review of the literature	10
Comparison of perioperative and survival outcomes between sublobar resection and lobectomy of patients who underwent a second pulmonary resection	10
Epicardial carvernous hemangioma: The diagnostic challenge of a middle mediastinal mass	10
Large pulmonary sclerosing pneumocytoma in a young female: A rare lung tumor	10
Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: A case report	10
	10
Evaluation of pain levels treated by the distal end of the hook‐wire positioning needle: A randomized controlled study	10
Exploratory analysis to predict pneumonitis during durvalumab consolidation therapy for patients with locally advanced non‐small cell lung cancer from proteomic profiling of circulating extracellular	10
The survival after discontinuation of EGFR‐TKIs due to intolerable adverse events in patients with EGFR‐mutated non–small cell lung cancer	10
	10
Large cell neuroendocrine carcinoma of the lung controlled for 4 years by a single administration of pembrolizumab: A case report	10
Use of PD‐1 inhibitor tislelizumab in the treatment of advanced pulmonary sarcomatoid carcinoma: A case report	10
Association of optic nerve sheath lesion and brain or meningeal metastasis caused by lung cancer	10
Long‐term follow‐up of unresectable adenoid cystic carcinoma of the trachea and bronchus treated with high‐dose proton beam therapy: A report of two cases	10
Survival benefits from afatinib compared with gefitinib and erlotinib among patients with common EGFR mutation in first‐line setting	10
Clinical characteristics of patients with KRAS mutation detected by liquid biopsy	10
Angiosarcoma of breast and chest wall complicated with tuberculous empyema: A case report	10
Issue Information	10
Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland	10
Real‐world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non‐small cell lu	10
	10
The reversal of drug resistance by two‐dimensional titanium carbide Ti₂C (2D Ti2C) in non‐small‐cell lung cancer via the depletion of intracellular antioxidant reserves	10
Diabetic ketoacidosis shortly after COVID‐19 vaccination in a non–small‐cell lung cancer patient receiving combination of PD‐1 and CTLA‐4 inhibitors: A case report	9
Surgical outcomes for non‐small cell lung cancer in younger adults: A population‐based study	9
Circ_0002476 regulates cell growth, invasion, and mtDNA damage in non–small cell lung cancer by targeting miR‐1182/TFAM axis	9
Treatment with immune checkpoint inhibitors after EGFR‐TKIs in EGFR‐mutated lung cancer	9
Aspergillus ball crawling out of pulmonary bullae	9
Issue Information	9
Safety and efficacy of endobronchial ultrasound‐guided transbronchial needle aspiration (EBUS‐TBNA) for patients aged 80 years and older	9
Pulmonary mucoepidermoid carcinoma: A clinicopathological study of 45 patients	9
2024 multidisciplinary consensus on image‐guided lung tumor ablation from the Taiwan Academy of Tumor Ablation	9
Left pulmonary vein anatomical variation in Turner syndrome. Benefits of three‐dimensional visualization for surgical planning	9
Computed tomography‐based radiomics and clinical‐genetic features for brain metastasis prediction in patients with stage III/IV epidermal growth factor receptor‐mutant non‐small‐	9
Exosomal GPT2 derived from triple‐negative breast cancer cells promotes metastasis by activating BTRC	9
Thoracic skeletal muscle mass predicts mortality in patients with surgery for pleural empyema: A case control study	9
Capmatinib successfully overcomes tepotinib‐induced intolerable peripheral edema	9
Circ‐PITX1 promotes non‐small‐cell lung cancer progression through regulating ETS1 expression via miR‐615‐5p	9
	9

Is using a consolidation tumor ratio 0.5 as criterion feasible in daily practice? Evaluation of interobserver measurement variability of consolidation tumor ratio of lung cancer less than 3 cm in size	9
Sevoflurane suppresses the malignant progression of breast cancer via the hsa_circ_0000129/miR‐578/EPSTI1 axis	9
Adjuvant chemotherapy in node‐positive patients after esophagectomy for esophageal squamous cell carcinoma	9
Establishment and characterization of a novel highly malignant lung cancer cell line ZX2021H derived from a metastatic lymph node lesion	9
Risks of segmentectomy for interstitial pneumonia with diffuse pulmonary ossification	9
Correction to “Circ‐PDZD8 promotes cell growth and glutamine metabolism in non‐small cell lung cancer by enriching LARP1 via sequestering miR‐330‐5p”	9
Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer	9
	9
Combined targeting of EGFR and BRAF triggers regression of osimertinib resistance by using osimertinib and vemurafenib concurrently in a patient with heterogeneity between differ	9
Issue Information	9
MiR‐671‐5p sponging activity of circMMP1 promotes esophageal squamous cancer progression	9
Are more courses of immunochemotherapy beneficial for the short‐term outcome of locally advanced esophageal squamous cell carcinoma?	9
	9
Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer	9
Comparative efficacy of immune checkpoint inhibitors versus chemotherapy alone in diffuse pleural mesothelioma	9
Improved survival in patients with isolated liver metastasis at initial diagnosis with surgery at primary and metastatic sites: A population‐based study in patients with breast cancer	9
Issue Information	9
Station 3A lymph node dissection does not improve long‐term survival in right‐side operable non‐small‐cell lung cancer patients: A propensity score matching	8
Survival outcomes of east Asian patients with advanced non‐small cell lung cancer treated with first‐line EGFR tyrosine kinase inhibitors: A network meta‐analysis of real‐world evidence	8
The role of spleen radiomics model for predicting prognosis in esophageal squamous cell carcinoma patients receiving definitive radiotherapy	8
Stage IIIA Non‐Small Cell Lung Cancer Treatment and Outcomes: A Single Institution Retrospective Analysis	8
Efficacy of paclitaxel‐carboplatin with bevacizumab as a late‐line therapy for patients with advanced nonsquamous non‐small cell lung cancer: A platinum rechallenge	8
Diagnostic efficacy of sentinel lymph node in breast cancer under percutaneous contrast‐enhanced ultrasound: An updated meta‐analysis	8
Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer‐BioNTech)	8
Cetuximab enhances radiosensitivity of esophageal squamous cell carcinoma cells by G2/M cycle arrest and DNA repair delay through inhibiting p‐EGFR and p‐ERK	8
Prognostic factors for survival in extensive‐stage small cell lung cancer: An Italian real‐world retrospective analysis of 244 patients treated over the last decade	8
Efficacy and safety of 3 mg pegylated recombinant human granulocyte colony‐stimulating factor as support to chemotherapy for lung cancer	8
	8
Dosimetric comparison of five different radiotherapy treatment planning approaches for locally advanced non‐small cell lung cancer with sequential plan changes	8
PRPS2‐mediated modulation of the antitumor immune response in lung cancer through CCL2‐mediated tumor‐associated macrophages and myeloid‐derived suppressor cells	8
Detection of Overlooked Rare EGFR Mutations in Non‐small Cell Lung Cancer Using Multigene Testing	8
Pharmacokinetics of alectinib and its metabolite M4 in a patient with advanced lung adenocarcinoma undergoing hemodialysis: A case report	8
Successful restart of chemotherapy in a patient with primary mediastinal nonseminomatous germ cell tumor after COVID‐19 infection	8
Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradia	8
Disease control in patients with non‐small cell lung cancer using pemetrexed: Investigating the best treatment strategy	8
The Impact of Immune‐Related Adverse Event Severity on Prognosis in Elderly Patients With Nonsmall‐Cell Lung Cancer in First‐Line Immune Checkpoint Inhibitor Treatment	8
Intratumoral genetic and immune microenvironmental heterogeneity in T4N0M0 (diameter ≥ 7 cm) non‐small cell lung cancers	8
Recurrent esophageal adenocarcinoma derived from ectopic gastric mucosa: A case report	8
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624‐mediated PD‐L1 pathway	8
Pathological characteristics of lung tumors in Sri Lanka 2017–2021	8
N⁶‐methyladenosine‐modified circFUT8 competitively interacts with YTHDF2 and miR‐186‐5p to stabilize FUT8 mRNA to promote malig	8
SMARCA4‐deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report	8
The efficacy of almonertinib and anlotinib combination therapy for advanced non‐small‐cell lung cancer patients who continued to experience cancer progression during third‐generation EGFR‐TKI	8
Pericancerous lymph node imaging with indocyanine green‐guided near‐infrared fluorescence in radical esophagectomy: Protocol for a single‐center, prospective, randomized controlled clinical trial	8
3D Computed Tomography Reconstruction for Pre‐Operative Diagnosis of Anomalous Venous Drainage of the Right Upper Lobe	8
Effect of Transferrin‐Modified Fe₃O₄ Nanoparticle Targeted Delivery miR‐15a‐5p Combined With Photothermal Therapy on Lung Cancer	8
Operative outcomes and long‐term survival of patients undergoing colon interposition after esophagectomy for cancer	8
Extended ICI treatment after first‐line chemoimmunotherapy could predict the clinical benefit of ramucirumab plus docetaxel in advanced non‐small lung cancer: Post hoc analysis from NE	8
Pseudocirrhosis due to liver metastasis from lung adenocarcinoma	8
Issue Information	8
Diagnostic challenge and survival analysis of pulmonary oligometastases and primary lung cancer in breast cancer patients	8
Disease monitoring of epidermal growth factor receptor (EGFR)‐mutated non‐small‐cell lung cancer patients treated with tyrosine kinase inhibitors via EGFR status in circulating tumor D	8
Clinical characteristics of paraneoplastic neurological syndrome related to different pathological lung cancers	8
Survival and pretreatment prognostic factors for extensive‐stage small cell lung cancer: A comprehensive analysis of 358 patients	8
Comparison of primary and metastatic site‐related PD‐L1 expression in predicting ORR in patients with advanced NSCLC who received ICB‐based therapy	8
Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors	8
Oral compound probiotic supplements can improve the quality of life for patients with lung cancer during chemotherapy: A randomized placebo‐controlled study	8
Relationship between immune‐related adverse events and treatment effectiveness in extensive disease small cell lung cancer	8
Establishing a new human lung squamous cell carcinoma cell line, OMUL‐1, expressing insulin‐like growth factor 1 receptor and programmed cell death ligand 1	8
Neoadjuvant chemotherapy with liposomal paclitaxel plus platinum for locally advanced esophageal squamous cell cancer: Results from a retrospective study	8
Relationship between the severity of emphysematous change in the lung and morbidity after esophagectomy for esophageal cancer: A retrospective study on a novel strategy for risk prediction	7
Lung squamous cell carcinoma responding to nivolumab retreatment six years after initial treatment: A case report	7
Comparison of SP263 and 22C3 pharmDx assays to test programmed death ligand‐1 (PD‐L1) expression in surgically resected non‐small cell lung cancer	7
C‐PLAN index as a prognostic factor for patients with previously untreated advanced non‐small cell lung cancer who received combination immunotherapy: A multicenter retrospective study	7
Serum miR‐205‐5p level for non–small‐cell lung cancer diagnosis	7
Inherent PD‐L1 22C3 Expression in Alveolar Macrophages Impacts the Combined Positive Score Status in Breast Cancer With Pulmonary Metastasis	7
Issue Information	7
Multi‐center experience in an optimized right upper lobectomy surgical procedure in China	7
NLR, MLR, and PLR are adverse prognostic variables for sleeve lobectomy within non‐small cell lung cancer	7
Safety and efficacy of microwave ablation for lung cancer adjacent to the interlobar fissure	7
Prognostic value of ferroptosis‐related genes in patients with lung adenocarcinoma	7
Treatment patterns and outcomes of immunotherapy in extensive‐stage small‐cell lung cancer based on real‐world practice	7
Clinical case of lung spindle cell carcinoma markedly responsive to pembrolizumab	7
Identification of a DNA damage repair gene‐related signature for lung squamous cell carcinoma prognosis	7
Relapse predictability of topological signature on pretreatment planning CT images of stage I non‐small cell lung cancer patients before treatment with stereotactic ablative radiotherapy	7
Differential diagnosis of lung cancer and benign lung lesion using salivary metabolites: A preliminary study	7
Comparison of Early Functional Recovery Following Triportal Robot‐Assisted and Uniportal Video‐Assisted Segmentectomy in Patients With Early‐Stage Non‐Small Cell Lung Cancer: A Propensity Score‐Matche	7
Impact of Neoadjuvant and Adjuvant Pleural Intensity‐Modulated Radiotherapy in Multimodality Treatment for Malignant Pleural Mesothelioma	7
Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer	7
A case of eosinophilic bronchiolitis after the initiation of immune checkpoint inhibitor	7
Esophageal submucosal tumor diagnosed with EBUS‐guided transbronchial mediastinal cryobiopsy: A case report	7
Secular trends of morbidity and mortality of thyroid cancer in five Asian countries from 1990 to 2019 and their predictions to 2035	7
Elevated neutrophil‐to‐lymphocyte ratio (NLR) is associated with poorer progression‐free survival in unresectable stage III NSCLC treated with consolidation durvalumab	7
Risk factors for acute exacerbation in lung cancer complicated by interstitial lung disease with slight reticular shadows	7
Issue Information	7
ITCH facilitates proteasomal degradation of TXNIP in hypoxia‐ induced lung cancer cells	7
Impacts of additional cycles of neoadjuvant immunotherapy on surgery in non‐small‐cell lung cancer	7
Clinical characteristics of myasthenia gravis (MG) patients developing other autoimmune diseases after thymectomy from one single center cohort	7
Lung Adenocarcinoma With Initially Co‐Occurring EGFR and BRAF Double Mutation: A Case Report and Literature Review	7
HOXA5 Derives the Malignant Progression and Cisplatin Resistance of Esophageal Squamous Cell Carcinoma by Regulating USP18‐Mediated IFI27 Deubiquitination	7
Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score‐matched analysis	7
Diagnostic yield of radial probe endobronchial ultrasonography‐guided transbronchial biopsy without fluoroscopy in peripheral pulmonary lesions: A systematic review and meta‐analysis	7
Clinical characteristics and prognostic impact of acute exacerbations in patients with interstitial lung disease and lung cancer: A single‐center, retrospective cohort study	7
Second‐line lurbinectedin as a new treatment option for small‐cell lung cancer: Preliminary results in real‐clinical practice	7
Real‐world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non‐small cell lung cancer	7